Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Biotechnol Lett ; 43(5): 1063-1073, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33591463

RESUMEN

OBJECTIVES: To elucidate the molecular mechanisms involved in the substrate interaction of the bile salt hydrolase of Lactobacillus reuteri CRL 1098 (LrBSH) with bile acids (BAs) and to evaluate potential enzyme inhibitors based on computer and in vitro modeling assays. RESULTS: Asp19, Asn79, and Asn171 participated in the LrBSH interaction with all BAs tested while Leu56 and Glu 222 played an important role in the interaction with glyco- and tauro-conjugated BAs, respectively. A great percentage of hydrophobic and polar interactions were responsible for the binding of LrBSH with glyco- and tauro-conjugated BAs, respectively. Remarkably, the four binding pocket loops participated in the substrate binding site of LrBSH unlike most of the reported BSHs. Inhibition assays showed that ascorbic acid, citric acid, penicillin G, and ciprofloxacin decreased LrBSH activity by 47.1%, 40.14%, 28.8%, and 9%, respectively. Docking analysis revealed that tetracycline and caffeic acid phenethyl ester had the low binding energy (-7.32 and -7.19 kcal/mol, respectively) and resembled the interaction pattern of GDCA (-6.88 kcal/mol) while penicillin (-6.25 kcal/mol) and ascorbic acid (-5.98 kcal/mol) interacted at a longer distance. CONCLUSION: This study helps to delve into the molecular mechanisms involved in the recognition of substrates and potential inhibitors of LrBSH.


Asunto(s)
Amidohidrolasas/química , Proteínas Bacterianas/química , Inhibidores Enzimáticos/química , Limosilactobacillus reuteri/enzimología , Amidohidrolasas/antagonistas & inhibidores , Amidohidrolasas/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/antagonistas & inhibidores , Ácidos y Sales Biliares/química , Sitios de Unión , Dominio Catalítico , Modelos Moleculares , Simulación del Acoplamiento Molecular , Dominios Proteicos , Especificidad por Sustrato
2.
Molecules ; 23(4)2018 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-29570644

RESUMEN

Fluoroquinolones (FQs) constitute an important class of biologically active broad-spectrum antibacterial drugs that are which are in contact with many biological fluids under different acidity conditions. We studied the reactivity of ciprofloxacin (Cpx) and levofloxacin (Lev) and their interaction with lysozyme (Lyz) at different pH values, using UV-visible absorption, fluorescence, infrared spectroscopies supported by DFT calculation and docking. In addition, by antimicrobial assays, the biological consequences of the interaction were evaluated. DFT calculation predicted that the FQ cationic species present at acid pH have lower stabilization energies, with an electric charge rearrangement because of their interactions with solvent molecules. NBO and frontier orbital calculations evidenced the role of two charged centers, NH2⁺ and COO-, for interactions by electronic delocalization effects. Both FQs bind to Lyz via a static quenching with a higher interaction in neutral medium. The interaction induces a structural rearrangement in ß-sheet content while in basic pH a protective effect against the denaturation of Lyz was inferred. The analysis of thermodynamic parameters and docking showed that hydrophobic, electrostatic forces and hydrogen bond are the responsible of Cpx-Lyz and Lev-Lyz associations. Antimicrobial assays evidenced an antagonist effect of Lyz in acid medium while in neutral medium the FQs' activities were not modified by Lyz.


Asunto(s)
Antiinfecciosos/química , Fluoroquinolonas/química , Muramidasa/química , Interacciones Hidrofóbicas e Hidrofílicas
3.
Food Technol Biotechnol ; 55(3): 381-389, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29089851

RESUMEN

In this work, autochthonous lactic acid bacteria (LAB) were isolated from chia (Salvia hispanica L.) dough and selected on the basis of the kinetics of acidification and proteolytic activity. Strain no. C8, identified as Lactobacillus plantarum C8, was selected and used as starter to obtain chia sourdough. Lactic acid fermentation increased the organic acid mass fractions (lactic, acetic and phenyl lactic acids to 12.3 g, 1.0 g and 23.8 µg per kg of dough respectively), and antioxidant activities, which increased by approx. 33-40% compared to unfermented chia flour dough. In addition, total phenolic content increased 25% and its composition was strongly modified after 24 h of fermentation by L. plantarum C8. Chlorogenic acid was only found in the fermented dough (2.5 mg/g), while ferulic acid was detected from the beginning of fermentation, being 32% higher in chia sourdough (5.6 mg/g). The use of fermented chia sourdough improved the overall characteristics of white bread, including physical (e.g. reduced hardness and chewiness of the crumb) and antioxidant properties (25% on average), compared to the white bread. These results indicate that the use of chia sourdough could be a promising alternative to improve the technological and antioxidant properties of wheat bread. In addition, this work has shown, for the first time, that lactic acid bacterium is able to ferment chia dough, improving its overall characteristics.

4.
BMC Microbiol ; 16(1): 240, 2016 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-27737643

RESUMEN

BACKGROUND: Despite the fact that most vitamins are present in a variety of foods, malnutrition, unbalanced diets or insufficient intake of foods are still the cause of vitamin deficiencies in humans in some countries. Vitamin B12 (Cobalamin) is a complex compound that is only naturally produced by bacteria and archea. It has been reported that certain strains belonging to lactic acid bacteria group are capable of synthesized water-soluble vitamins such as those included in the B-group, as vitamin B12. In this context, the goal of the present paper was to evaluate and characterize the production of vitamin B12 in Lactobacillus coryniformis CRL 1001, a heterofermentative strain isolated from silage. RESULTS: Cell extract of L. coryniformis CRL 1001, isolated from silage, is able to correct the coenzyme B12 requirement of Salmonella enterica serovar Typhimurium AR 2680 in minimal medium. The chemical characterization of the corrinoid-like molecule isolated from CRL 1001 cell extract using HPLC and mass spectrometry is reported. The majority of the corrinoid produced by this strain has adenine like Coα-ligand instead 5,6-dimethylbenzimidazole. Genomic studies revealed the presence of the complete machinery of the anaerobic biosynthesis pathway of coenzyme B12. The detected genes encode all proteins for the corrin ring biosynthesis and for the binding of upper (ß) and lower (α) ligands in one continuous stretch of the chromosome. CONCLUSIONS: The results here described show for the first time that L. coryniformis subsp. coryniformis CRL 1001 is able to produce pseudocobalamin containing adenine instead of 5,6-dimethlbenzimidazole in the Coα-ligand. Genomic analysis allowed the identification and characterization of the complete de novo biosynthetic pathway of the corrinoid produced by the CRL 1001 strain.


Asunto(s)
Lactobacillus/genética , Lactobacillus/metabolismo , Familia de Multigenes , Vitamina B 12/biosíntesis , Vitamina B 12/genética , Adenina/metabolismo , Anaerobiosis , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Bencimidazoles/metabolismo , Cromatografía Líquida de Alta Presión/métodos , Cobamidas/genética , Cobamidas/metabolismo , Genes Bacterianos , Lactobacillus/aislamiento & purificación , Espectrometría de Masas/métodos , Sistemas de Lectura Abierta , Salmonella enterica/genética , Salmonella enterica/metabolismo , Salmonella typhimurium/genética , Análisis de Secuencia de Proteína , Ensilaje/microbiología , Vitamina B 12/química , Vitamina B 12/aislamiento & purificación
5.
Artículo en Inglés | MEDLINE | ID: mdl-38829565

RESUMEN

In recent years, more and more scientific community, food producers, and food industry show increased interest in functional foods containing probiotics, which is a big challenge. The consumption of probiotics in the context of a balanced diet through the consumption of functional foods or through the intake of pharmaceutical preparations has proven to contribute to the improvement of human health, even contributing to the prevention of diseases. In order for probiotics to be considered suitable for consumption, they must contain a minimum concentration of viable cells, namely, at least 107 colony forming units of beneficial microbes per gram. Ensuring the viability of bacterial cells until the moment of consumption is the overriding priority of functional probiotic food manufacturers. Probiotic bacteria are subject to stress conditions not only during food manufacturing but also during gastrointestinal passage, which limit or even compromise their functionality. This paper first examines all the stressful conditions faced by probiotic cells in their production stages and related to the conditions present in the bioreactor fermentation and drying processes as well as factors related to the food matrix and storage. The stress situations faced by probiotic microorganisms during the gastrointestinal transit especially during stomach and intestinal residence are also analyzed. In order to understand the adaptation mechanisms of probiotic bacteria to gastrointestinal stress, intrinsic and adaptive mechanisms identified in probiotic strains in response to acid stress and to bile and bile acid stress are analyzed. In addition, improvement strategies for multiple stress tolerance of lactic acid bacteria through directions dealing with stress, accumulation of metabolites, use of protectants, and regulation of technological parameters are examined. Finally, the definition of postbiotics, inanimate microorganisms and/or their components conferring health benefits, is also introduced. Postbiotics include cell lysates, enzymes, and cell wall fragments derived from probiotic bacteria and may represent an alternative to the use of probiotics, when they do not tolerate stressful conditions.

6.
ACS Omega ; 8(50): 48042-48049, 2023 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-38144080

RESUMEN

In the past 50 years, life expectancy has increased by more than 20 years. One consequence of this increase in longevity is the rise of age-related diseases such as dementia. Alzheimer's disease (AD) is the most common form of dementia, accounting for 60-70% of cases. AD pathogenesis is not restricted to the neuronal compartment but includes strong interactions with other brain cells, particularly microglia triggering the release of inflammatory mediators, which contribute to disease progression and severity. There is growing evidence revealing the diverse clinical benefits of postbiotics in many prevalent conditions, including neurodegenerative diseases. Here, we tested the ability of bacterial conditioned media (BCM) derived from selected lactic acid bacteria (LAB) strains to regulate core mechanisms relevant to AD pathophysiology in the microglia cell line BV-2. Levilactobacillus brevis CRL 2013, chosen for its efficient production of the neurotransmitter GABA, and Lactobacillus delbrueckii subsp. lactis CRL 581, known for its anti-inflammatory properties, were selected alongside Enterococcus mundtii CRL 35, a LAB strain that can significantly modulate cytokine production. BCM from all 3 strains displayed antioxidant capabilities, reducing oxidative stress triggered by beta-amyloid oligomers (oAß1-42). Additionally, BCM effectively mitigated the expression of inflammatory cytokines, namely, TNF-α, IL-1ß, and IL-6 triggered by oAß1-42. Furthermore, our study identified that BCM from CRL 581 inhibit the activity of acetylcholinesterase (AChE), a crucial enzyme in AD progression, in both human erythrocytes and mouse brain tissues. Notably, the inhibitory effect was mediated by low-molecular-weight components of the BCM. L. delbrueckii subsp. lactis CRL 581 emerged as a favorable candidate for production of postbiotics with potential benefits for AD therapy since it demonstrated potent antioxidant activity, reduction of cytokine expression, and partial AChE inhibition. On the other hand, E. mundtii CRL 35 showed that the antioxidant activity failed to inhibit AChE and caused induction of iNOS expression, rendering it unsuitable as a potential therapeutic for AD. This study unveils the potential benefits of LAB-derived postbiotics for the development of new avenues for therapeutic interventions for AD.

7.
J Bacteriol ; 194(2): 538-9, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22207745

RESUMEN

Lactobacillus curvatus is one of the most prevalent lactic acid bacteria found in fermented meat products. Here, we present the draft genome sequence of Lactobacillus curvatus CRL705, a bacteriocin producer strain isolated from an Argentinean artisanal fermented sausage, which consists of 1,833,251 bp (GC content, 41.9%) and two circular plasmids of 12,342 bp (pRC12; GC, 43.9%) and 18,664 bp (pRC18; GC, 34.4%).


Asunto(s)
Genoma Bacteriano , Lactobacillus/clasificación , Lactobacillus/genética , Fermentación , Microbiología de Alimentos , Productos de la Carne/microbiología , Datos de Secuencia Molecular
8.
J Bacteriol ; 194(2): 550, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22207752

RESUMEN

We report the draft genome sequence of Enterococcus mundtii CRL1656, which was isolated from the stripping milk of a clinically healthy adult Holstein dairy cow from a dairy farm of the northwestern region of Tucumán (Argentina). The 3.10-Mb genome sequence consists of 450 large contigs and contains 2,741 predicted protein-coding genes.


Asunto(s)
Enterococcus/clasificación , Enterococcus/genética , Genoma Bacteriano , Animales , Argentina/epidemiología , Bovinos , Femenino , Mastitis Bovina/epidemiología , Mastitis Bovina/microbiología , Leche/microbiología , Datos de Secuencia Molecular
9.
Biotechnol Lett ; 34(8): 1511-8, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22526425

RESUMEN

The effect of the conjugated bile acid (BA) on the microbial internal pH (pHin) values in lactic acid bacteria with and without ability to hydrolyze bile salts (BSH[+] and BSH[-] strains, respectively) was evaluated. BSH(+) strains showed a gradual increase in the pHin following the addition of conjugated BA; this behavior was more pronounced with GDCA than with TDCA may be due to the higher affinity of BSH for the glyco-conjugates acids. Conversely, the BSH(-) strains showed a decrease in internal pH probably as a consequence of weak acid accumulation. As expected, a decrease in the cytoplasmatic pH affected the cell survival in this last group of strains, while the BSH(+) strains were more resistant to the toxic effect of BA. PURPOSE OF WORK: To evaluate bile salt hydrolase activities, changes in the internal pH and cell survival to bile acids in lactic acid bacteria to establish the relationship between these parameters.


Asunto(s)
Amidohidrolasas/metabolismo , Proteínas Bacterianas/metabolismo , Ácidos y Sales Biliares/farmacología , Lactobacillales/efectos de los fármacos , Lactobacillales/metabolismo , Amidohidrolasas/genética , Proteínas Bacterianas/genética , Ácidos y Sales Biliares/metabolismo , Concentración de Iones de Hidrógeno , Hidrólisis , Espacio Intracelular/química , Espacio Intracelular/enzimología , Lactobacillales/enzimología , Lactobacillales/genética , Viabilidad Microbiana
10.
Biotechnol Lett ; 33(11): 2265-9, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21744273

RESUMEN

PURPOSE OF WORK: To study whether an active bile acid (BA) efflux occurs in Lactobacillus reuteri CRL 1098 as well as the nature (ATP or proton motive force [PMF] mediated primary transport) of the BA extrusion mechanism. BAs are powerful detergents which disorganize the lipid bilayer structure of cellular membranes. Specific bile resistance mechanisms (bile efflux, bile salt hydrolysis, and intrinsic architecture and composition of cell membrane the most prevalent) have been described in intestinal bacteria. L. reuteri, showed a significant degree of resistance to the toxic action of BA and the presence of an active efflux ATP-dependent of conjugated (taurocholic [TCA]) and free (cholic [CA]) BA in the CRL 1098 strain is now reported. However, due the high pKa (5.5) of cholic acid (CA) compared with the conjugated species, a significant fraction (between 35 and 50% at pH 6.5 and 5.2, respectively) of free BA also diffused passively, even in the absence of ATP. To our knowledge, our results represent the first evidence of ATP as the energy source involved in the BA extrusion in L. reuteri.


Asunto(s)
Adenosina Trifosfato/metabolismo , Ácido Cólico/metabolismo , Limosilactobacillus reuteri/metabolismo , Ácido Taurocólico/metabolismo , Transporte Biológico Activo , Ácido Cólico/toxicidad , Limosilactobacillus reuteri/efectos de los fármacos , Ácido Taurocólico/toxicidad
11.
Biotechnol Lett ; 33(7): 1389-94, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21365290

RESUMEN

PURPOSE OF WORK: To apply a fluorescent dye as an alternative technique to evaluate the survival of potentially probiotic lactobacilli to bile acids (BA) as first step in the design of probiotic functional foods. The use of lactic acid bacteria (LAB) in the functional food design depends on their ability to survive in the gastrointestinal tract where bile is an important natural barrier. Bile is mainly constituted by conjugated BA, which can be hydrolyzed to free BA and taurine or glycine. Changes in the transmembrane electrical potential (ΔΨ) of probiotic LAB strains due to the effect of conjugated and free BA were measured and showed that the majority of the tested LAB strains had greater sensibility to free BA than to their respective conjugated acids. Variations in the ΔΨ of the microorganism correlated well with bacterial viability determined by standard plate count method. We therefore propose the DiSC(3)-based fluorescent technique as a rapid and effective method to evaluate the resistance of probiotic lactobacilli to bile as first step for strain selection to be included in functional foods.


Asunto(s)
Antibacterianos/toxicidad , Técnicas Bacteriológicas/métodos , Ácidos y Sales Biliares/toxicidad , Lactobacillus/efectos de los fármacos , Viabilidad Microbiana/efectos de los fármacos , Probióticos , Coloración y Etiquetado/métodos , Membrana Celular/efectos de los fármacos , Colorantes Fluorescentes/metabolismo , Potenciales de la Membrana/efectos de los fármacos
12.
Pharmaceutics ; 13(7)2021 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-34209453

RESUMEN

BACKGROUND: Probiotic bacteria have been emerging as a trustworthy choice for the prevention and treatment of Candida spp. infections. This study aimed to develop and characterize an orodispersible film (ODF) for delivering the potentially probiotic Enterococcus faecium CRL 183 into the oral cavity, evaluating its in vitro antifungal activity against Candida albicans. METHODS AND RESULTS: The ODF was composed by carboxymethylcellulose, gelatin, and potato starch, and its physical, chemical, and mechanical properties were studied. The probiotic resistance and viability during processing and storage were evaluated as well as its in vitro antifungal activity against C. albicans. The ODFs were thin, resistant, and flexible, with neutral pH and microbiologically safe. The probiotic resisted the ODF obtaining process, demonstrating high viability (>9 log10 CFU·g-1), up to 90 days of storage at room temperature. The Probiotic Film promoted 68.9% of reduction in fungal early biofilm and 91.2% in its mature biofilm compared to the group stimulated with the control film. Those results were confirmed through SEM images. CONCLUSION: The probiotic ODF developed is a promising strategy to prevent oral candidiasis, since it permits the local probiotic delivery, which in turn was able to reduce C. albicans biofilm formation.

13.
Biochimie ; 168: 185-189, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31715214

RESUMEN

Lactobacillus coryniformis CRL 1001 and L. reuteri CRL 1098 have the complete genes necessary to synthesize pseudo-cobalamin as final product in a vitamin B12 free commercial medium. Unlike vitaminB12 (the most biologically active form), the pseudo-cobalamin contains adenine instead of 5,6-dimethlbenzimidazole (DMB) in the Coα-ligand. Considering the vitamin B12-gene clusters of these bacteria, the aim of this work was to analyze the production of corrinoids with DMB (vitamin B12) instead of adenine (pseudo-B12) as lower ligand base in a vitamin B12 free chemically defined medium (CDM) without purines. Genome-wide screening of genes related to purine metabolism showed that both strains possess all pur genes necessary for the synthesis of inositol monophosphate, the main precursor for purine biosynthesis. Accordingly, both strains were able to grow in B12 free CDM without purines, with the supplementation of different synthetic intermediaries. Isolated compounds with positive vitamin B12 activity were quantified and characterized by LC/MS-MS. Total corrinoids values were higher for both strains in comparison to those obtained in vitaminB12 free commercial medium. Interestingly, CRL 1001 strain synthesized cobalamin, suggesting that this strain is able to activate DMB as nitrogenous base instead adenine when it is in excess in a purine-free medium. The present paper represents the first demonstration of a partial metabolic shift to produce vitamin B12 in a Lactobacillus strain.


Asunto(s)
Lactobacillus/metabolismo , Limosilactobacillus reuteri/metabolismo , Purinas/metabolismo , Vitamina B 12/análogos & derivados , Vitamina B 12/metabolismo , Medios de Cultivo/metabolismo , Redes y Vías Metabólicas
14.
Front Microbiol ; 9: 2256, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30319575

RESUMEN

Vitamin B12 or cobalamin is an essential metabolite for humans, which makes it an interesting compound for many research groups that focus in different producer-strains synthesis pathways. In this work, we report the influence of key intermediaries for cobalamin synthesis added to the culture medium in two Lactobacillus (L.) strains, L. reuteri CRL 1098 and L. coryniformis CRL 1001. Here, we report that addition of Co2+ and 5,6-dimethylbenzimidazole increased the corrinoid compounds production in both strains while addition of L-threonine increased only the corrinoid compounds production by CRL 1001 strain. Then, we purified and characterized by LC-MS the corrinoid compounds obtained. Physiological studies besides in silico analysis revealed that L. reuteri CRL 1098 and L. coryniformis CRL 1001 follow different pathways for the last steps of the corrinoid compounds synthesis.

15.
Res Microbiol ; 157(8): 720-5, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16730163

RESUMEN

Lactic acid bacteria and other species dwelling in the gut must be tolerant to bile salts. This study sought to determine the effects of the bile salts taurodeoxycholate (TDCA) and deoxycholate (DCA) on Lactobacillus reuteri CRL 1098, a strain of likely probiotic value. When compared to other lactobacilli, L. reuteri showed the highest survival rate but remained sensitive to high (>3 mM) DCA concentrations. DCA produced complete permeabilization of cells, abolished glucose uptake and severely distorted the cell envelope, as shown by electron microscopy. Detailed analytical studies revealed a change in the phospholipid to glycolipid ratio, and also in lipid proportions. The C18:1 W9C form remarkably increased, possibly following a rapid adaptive response during DCA treatment. This study provides the first solid evidence of the mechanism of DCA toxicity in a lactic acid bacterium.


Asunto(s)
Membrana Celular/efectos de los fármacos , Ácido Desoxicólico/farmacología , Lactobacillus/efectos de los fármacos , Ácido Taurodesoxicólico/farmacología , Membrana Celular/ultraestructura , Permeabilidad de la Membrana Celular/efectos de los fármacos , Glucosa/metabolismo , Glucolípidos/análisis , Lactobacillus/fisiología , Lactobacillus/ultraestructura , Limosilactobacillus reuteri/efectos de los fármacos , Limosilactobacillus reuteri/fisiología , Limosilactobacillus reuteri/ultraestructura , Lípidos de la Membrana/análisis , Viabilidad Microbiana/efectos de los fármacos , Microscopía Electrónica de Transmisión , Fosfolípidos/análisis
16.
Genome Announc ; 4(4)2016 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-27563038

RESUMEN

We report here the draft genome sequence of Lactobacillus reuteri strain CRL 1098. This strain represents an interesting candidate for functional food development because of its proven probiotic properties. The draft genome sequence is composed of 1,969,471 bp assembled into 45 contigs and an average G+C content of 38.8%.

17.
Methods Mol Biol ; 268: 417-22, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15156052

RESUMEN

For many years, it has been recognized that elevated serum cholesterol is a risk factor associated with atherosclerosis and coronary heart disease, the latter being a major cause of death in Western countries. Numerous drugs that lower cholesterol have been used to treat hypocholesterolemic individuals. However, the undesirable side effects of these compounds have caused concerns about their therapeutic use. Ingestion of probiotic (beneficial for health) lactic acid bacteria (LAB) would possibly be a more natural method to decrease serum cholesterol in humans, as has been was reported. Previous studies have demonstrated that Lactobacillus reuteri administered in low doses has a hypocholesterolemic effect both therapeutically and preventively. One of the key studies in the development of a probiotic is to determine the minimal effective dose of live microorganisms that might be ingested without producing adverse effects (i.e., translocation) in the host. In this chapter, we describe an animal model that allows us to evaluate reduction in hypercholesterolemia by LAB and, also to determine the minimal dose of the microorganism, a critical step in the development of a safe probiotic product.


Asunto(s)
Anticolesterolemiantes , Colesterol/sangre , Bacterias Grampositivas , Hipercolesterolemia/terapia , Probióticos , Alimentación Animal , Animales , Traslocación Bacteriana , Dieta , Modelos Animales de Enfermedad , Bacterias Grampositivas/fisiología , Hipercolesterolemia/sangre , Masculino , Ratones
18.
Int J Food Microbiol ; 88(2-3): 241-5, 2003 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-14596996

RESUMEN

One hundred twenty-two strains of Enterococcus faecium isolated from Tafí Cheese, a homemade traditional cheese of the highlands in the province of Tucumán, Argentina, were evaluated for their potential application as starter cultures in the manufacture of this traditional cheese. Eleven of the 122 strains showing limited delays in growth in oxgall were selected for the study of bile salts hydrolase activity (BSH), cholesterol reduction, antimicrobial activity, and virulence determinants. Nine strains were able to remove cholesterol in in vitro assays, a property that was closely related to the bile salt hydrolase activity. Only two strains produced active bacteriocins against Listeria strains although genetic evidence for the bacteriocin structural gene was found in six other enterococci strains. No virulence factors were detected in any of the 11 selected strains of enterococci.


Asunto(s)
Queso/microbiología , Enterococcus faecium/aislamiento & purificación , Microbiología de Alimentos , Probióticos , Argentina , Bacteriocinas/biosíntesis , Bacteriocinas/genética , Colesterol/metabolismo , ADN Bacteriano/análisis , Enterococcus faecium/enzimología , Enterococcus faecium/genética , Hidrolasas/metabolismo , Listeria/efectos de los fármacos , Listeria/crecimiento & desarrollo , Reacción en Cadena de la Polimerasa
19.
Genome Announc ; 1(4)2013 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-23929489

RESUMEN

We report the genome sequence of Lactobacillus delbrueckii subsp. lactis CRL 581 (1,911,137 bp, GC 49.7%), a proteolytic strain isolated from a homemade Argentinian hard cheese which has a key role in bacterial nutrition and releases bioactive health-beneficial peptides from milk proteins.

20.
Genome Announc ; 1(4)2013 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-23950129

RESUMEN

We report the draft genome sequence of the probiotic Lactobacillus rhamnosus strain CRL1505. This new probiotic strain has been included into official Nutritional Programs in Argentina. The draft genome sequence is composed of 3,417,633 bp with 3,327 coding sequences.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA